Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Potential role of NF-kappaB in esophageal adenocarcinoma: as an emerging molecular target.

Abdel-Latif MM, Kelleher D, Reynolds JV.

J Surg Res. 2009 May 1;153(1):172-80. doi: 10.1016/j.jss.2007.12.755. Epub 2008 Jan 10. Review.

PMID:
18533190
2.

Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.

Allen CT, Ricker JL, Chen Z, Van Waes C.

Head Neck. 2007 Oct;29(10):959-71. Review.

PMID:
17405170
3.

The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.

Mauro C, Zazzeroni F, Papa S, Bubici C, Franzoso G.

Methods Mol Biol. 2009;512:169-207. doi: 10.1007/978-1-60327-530-9_10.

PMID:
19347278
4.

Activated nuclear factor-kappa B and cytokine profiles in the esophagus parallel tumor regression following neoadjuvant chemoradiotherapy.

Abdel-Latif MM, O'Riordan JM, Ravi N, Kelleher D, Reynolds JV.

Dis Esophagus. 2005;18(4):246-52.

PMID:
16128781
5.

Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma.

Izzo JG, Correa AM, Wu TT, Malhotra U, Chao CK, Luthra R, Ensor J, Dekovich A, Liao Z, Hittelman WN, Aggarwal BB, Ajani JA.

Mol Cancer Ther. 2006 Nov;5(11):2844-50.

6.

Effect of NF-κB signaling on apoptosis in chronic inflammation-associated carcinogenesis.

Wang H, Cho CH.

Curr Cancer Drug Targets. 2010 Sep;10(6):593-9. Review.

PMID:
20482486
7.

Therapy-induced expression of NF-kappaB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation.

Izzo JG, Wu X, Wu TT, Huang P, Lee JS, Liao Z, Lee JH, Bhutani MS, Hofstetter W, Maru D, Hung MC, Ajani JA.

Dis Esophagus. 2009;22(2):127-32. doi: 10.1111/j.1442-2050.2008.00884.x. Epub 2008 Nov 19.

PMID:
19021681
8.

Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression.

Izzo JG, Malhotra U, Wu TT, Luthra R, Correa AM, Swisher SG, Hofstetter W, Chao KS, Hung MC, Ajani JA.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1200-5.

9.
10.

NF-kappaB: a potential target for cancer chemoprevention and therapy.

Sarkar FH, Li Y.

Front Biosci. 2008 Jan 1;13:2950-9. Review.

PMID:
17981768
11.

Cytokines, NF-kappaB, microenvironment, intestinal inflammation and cancer.

Schottelius AJ, Dinter H.

Cancer Treat Res. 2006;130:67-87. Review.

PMID:
16610703
12.

Regulation of NF-kappaB transcriptional activity.

Vermeulen L, Vanden Berghe W, Haegeman G.

Cancer Treat Res. 2006;130:89-102. Review.

PMID:
16610704
13.

Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.

Ma G, Tabanca N, Husnu Can Baser K, Kirimer N, Pasco DS, Khan IA, Khan SI.

Cancer Chemother Pharmacol. 2009 Mar;63(4):673-80. doi: 10.1007/s00280-008-0784-9. Epub 2008 Jul 3.

PMID:
18597088
14.
15.

Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.

Park J, Ahn KS, Bae EK, Kim BS, Kim BK, Lee YY, Yoon SS.

Anticancer Drugs. 2008 Sep;19(8):777-82. doi: 10.1097/CAD.0b013e32830c236a.

PMID:
18690088
16.
17.

NF-kappa B signaling and carcinogenesis.

Okamoto T, Sanda T, Asamitsu K.

Curr Pharm Des. 2007;13(5):447-62. Review.

PMID:
17348842
18.

Nuclear factor-kappaB: the enemy within.

Aggarwal BB.

Cancer Cell. 2004 Sep;6(3):203-8. Review.

19.

Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis.

Sethi G, Ahn KS, Aggarwal BB.

Mol Cancer Res. 2008 Jun;6(6):1059-70. doi: 10.1158/1541-7786.MCR-07-2088.

20.

Nuclear factor-kappaB in cancer development and progression.

Karin M.

Nature. 2006 May 25;441(7092):431-6. Review.

PMID:
16724054
Items per page

Supplemental Content

Write to the Help Desk